Consistent with the results of the subcutaneous Phase 2 trial, GI-related adverse events were generally observed early in treatment, with decreasing frequency upon repeat dosing
They may also help with lowering the risk of heart attack, stroke and death in adults who have type 2 diabetes as well as those are obese and have heart disease
Incompatibilities: Avoid strong reducing agents, EDTA, and high-affinity copper chelators they will strip the copper from the GHK-Cu component and disrupt blend activity
Patients in our concierge program have direct, ongoing access in Austin, Houston, Dallas-Fort Worth, and Coastal Virginia, plus telemedicine support nationwide
Listen to your body and allow for rest days to support muscle recovery and prevent burnout